Immediate Impact

57 standout
Sub-graph 1 of 24

Citing Papers

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Combating Antibiotic-Resistant Bacterial Infection Using Coassembled Dimeric Antimicrobial Peptide-Based Nanofibers
2025 Standout
2 intermediate papers

Works of Krishna P. Allamneni being referenced

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group
2017
Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation
2015

Author Peers

Author Last Decade Papers Cites
Krishna P. Allamneni 17 12 66 57 37 10 192
Nikki E. Hall 7 10 96 133 164 14 296
Hendrik Reuter 16 6 22 109 22 15 287
Tiago Bordeira Gaspar 33 36 39 73 22 11 251
Rolf Baß 12 26 133 54 143 13 298
Kosei Inui 32 57 20 67 43 14 247
Donald Prater 5 15 58 35 32 13 244
Anne Graupner 11 25 70 112 113 13 262
Steven A. Stefanski 18 35 126 74 74 12 292
E Petrakou 18 12 21 46 43 8 141
Hilada Nefić 12 17 44 70 97 16 276

All Works

Loading papers...

Rankless by CCL
2026